Ipsos ASI Introduces Live|Test Solution for Better Digital Brand Performance
Ipsos Healthcare’s Molecular Diagnostics (MDx) Portfolio has arrived in Japan and Australia. The MDx Monitors – already running in the USA and 5EU – reveal the drivers and barriers within the MDx landscape, as well as their impact on diagnosis, management and treatment. Currently, the monitors focus on oncology, with other therapy areas to be rolled out in the upcoming months.
Let's ride upon the Latin wind! Focus on 4 countries in South America